31 results
Thumbnail

D2.82 - Association between additional corticosteroid usage and Uncontrolled Severe Asthma: A Retrospective Study Using the China Regional Database

Thumbnail

D2.83 - Correct Inhaler Technique as a Key Element of Asthma Management: Post-Education Evaluation of Patients' Knowledge

Thumbnail

D2.84 - Heterogeneity of Elderly Asthma: a nationwide health and nutrition examination survey

Thumbnail

D2.85 - Living a Normal Life with Asthma: Development of a Conceptual Model

Thumbnail

D2.86 - Characteristics of Severe type 2 Asthma Patients in China: A Retrospective Observational Study

Thumbnail

D2.87 - Disease Burden of Severe Asthma Patients Treated with Medium and High Doses of ICS: A Regional Database Analysis from China

Thumbnail

D2.89 - Investigation of Asthma Characteristics in Women with Generalized Periodontitis and Polycystic Ovary Syndrome

Thumbnail

D2.90 - Decrease in New-Onset Asthma During the COVID-19 Pandemic

Thumbnail

D2.91 - Distribution of Patients with Asthma According to the New Immune Response Classification

Thumbnail

D2.92 - Comparison of responsiveness to bronchodilators using the 2021 or 2005 ATS/ERS guidelines: bicenter retrospective study

Thumbnail

D2.93 - Differential effects of dupilumab in women with severe uncontrolled asthma

Thumbnail

D2.94 - Loss of lung function at 5 years in patients with asthma: DECLIVEMS study

Thumbnail

D2.95 - Targeted CBT for persistent severe fatigue in a pulmonary rehabilitation setting: a case control study

Thumbnail

D2.96 - Frequency of Herpes Zoster in Asthma and Associated Factors

Thumbnail

D2.97 - “Can Do, Do Do“ in patients with severe uncontrolled asthma referred for pulmonary rehabilitation in the alpine climate

Thumbnail

D2.98 - Features of the course of the antenatal and neonatal period of children with bronchial asthma

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity